Synthesis and <i>in Vitro</i> and <i>in Vivo</i> Characteristics of an Iodinated Analogue of the β-Adrenoceptor Antagonist Carazolol
作者:Eric A. Dubois、Jan C. van den Bos、Tamme Doornbos、Peter A. P. M. van Doremalen、G. Aernout Somsen、Jozef A. J. M. Vekemans、Anton G. M. Janssen、Harry D. Batink、Gerard J. Boer、Martin Pfaffendorf、Eric A. van Royen、Pieter A. van Zwieten
DOI:10.1021/jm960122v
日期:1996.1.1
A new (radio)iodinated, beta-adrenoceptor ligand, (S)-(-)-4-[3-[(1,1-dimethyl-3-iodo-(2E)-propenyl)-amino]-2-hydroxypropoxy]carbazole (CYBL8E, 1), was prepared. 1 is an iodinated analogue of the high-affinity beta-adrenoceptor antagonist carazolol (2). The asymmetric synthesis was achieved in four steps starting from 4-hydroxycarbazole. The iodine-123-labeled form was obtained by an iododestannylation reaction with [I-123]NaI in the presence of H2O2. Using classical in vitro displacement experiments with membrane fractions of cardiac left ventricular muscle, 1 proved to have a high affinity for the receptor (K-i = 0.31 +/- 0.03). Biodistribution studies performed in New Zealand white rabbits demonstrated the specificity of the binding in vivo to the receptor. Uptake of [I-123]1 was reduced significantly in both atrial muscle, left ventricular muscle, frontal cortex, cerebellum, and striatum, by the pretreatment of the animals with different beta-adrenoceptor antagonists. In conclusion, 1 is a potent nonselective beta-adrenoceptor antagonist, which binds specifically to the beta-adrenoceptor in vivo, and is therefore a promising radioligand for the imaging of beta-adrenoceptors using single photon emission computerized tomography.